Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-24

Clinical Trial Update: Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial of perifosine in relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perifosine (perifosine)

Snippet

Sponsor: Daphne Friedman | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-01-24